Savolitinib for Treating Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Patients
Clinical trial NCT04923945 · COMPLETED
Trial details
- NCT number
- NCT04923945
- Sponsor
- Hutchison Medipharma Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-19
- Primary completion
- 2024-11-30
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.